Two patents currently held, every record listed here
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2031. from the record
Of the 1 now held by other companies, 1 name Fraunhofer Gesellschaft Zur Förderung der Angewandten Forschung e V as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2031
Next term end
2
Patent families
When these terms end
Each bar runs from grant to computed term end. 2015 to 2035.20192023202720312035
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Apr 2031 · High confidence
Also notable
Ends no later than Sep 2035 · Medium confidence
Vehicle Frame
US 8,944,492
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2031.
Percutaneously Deliverable Heart Valve
US 12,564,490
Granted 2026. Too new for citation comparison; protection runs to 2035. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Formerly held, still cited
Notable
Ends Mar 2035 · High confidence
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2035.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Percutaneously Deliverable Heart Valve | 1 in force | to Sep 2035 |
| Vehicle Frame | 1 in force | to Apr 2031 |
Patents held now
Soonest term end first.
Showing 1 to 2 of 2
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,944,492 | Vehicle Frame In force · High confidence | In force | High confidence | |
| US 12,564,490 | Percutaneously Deliverable Heart Valve held by Colibri Heart Valve In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 2: 1 patent in force now held by others · 77 patents ended · 6 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed